FDA approves blood typing tests

Jan 14, 2008

The U.S. Food and Drug Administration has licensed 14 new tests for determining a person's blood type.

"These 14 new tests will provide blood establishments and transfusion services with additional choices to help assure safe, well-matched transfusions," said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research. "The tests offer a broader diversity of reliable blood-typing tests and will help protect against product shortages."

Knowing the blood types for blood donors and patients is critical since patients might experience serious life-threatening reactions from mismatched transfused blood.

The OLYMPUS PK System Blood Group and Phenotyping Reagents use monoclonal antibodies to test for the A, B, O, and Rh factors, as well as for other factors that signify a rarer blood type, the FDA said.

The tests are manufactured by DIAGAST of Loos Cedex, France.

Copyright 2008 by United Press International

Explore further: FDA approves Eli Lilly's injectable diabetes drug

add to favorites email to friend print save as pdf

Related Stories

New branch added to European family tree

1 hour ago

The setting: Europe, about 7,500 years ago. Agriculture was sweeping in from the Near East, bringing early farmers into contact with hunter-gatherers who had already been living in Europe for tens of thousands ...

Recommended for you

Seniors successfully withdraw from meds

2 hours ago

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

Flu vaccine for expectant moms a top priority

20 hours ago

Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.

Experts want restrictions on testosterone drug use (Update)

Sep 17, 2014

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

User comments : 0